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Tuberculosis is the principal cause of death worldwide due to an infectious disease. The resurgence of 
tuberculosis, followed by the increase in prevalence of infections caused by nontuberculous 
mycobacteria (NTM), as well as the multi-drug resistance of mycobacteria to the majority of currently 
available antibiotics, have encouraged research for new antimycobacterial agents. Soil and water 
samples from different Moroccan biotopes, have led to the isolation of four bacterial strains (M, R, G 
and S), showing an inhibitory effect on mycobacterial growth. This effect was shown to be due to 
secreted substances in the growth medium. From subsequent analysis it was concluded that these 
strains produced different active substances. Sequencing of the 16S rRNA showed that these isolates 
belong to the genus Bacillus. The active substance from isolate M, showed the more important 
inhibitory effect on mycobacterial growth. It is precipitated with ammonium sulfate and lost all activity 
when treated with Proteinase K, revealing its protein nature. 
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INTRODUCTION 
 
Tuberculosis is a major public health problem (Musser, 
1995; Berthet et al., 1999; Rossetti et al., 2002; Chen et 
al., 2011). Nevertheless, as of 1952, with the discovery of 
effective antituberculosis agents and the begining of 
chemotherapy, the implementation of BCG (Bacille 
Calmette Guérin) vaccination programs (Ann Ginsberg, 
2002; Bonnaud, 1996), and the improvement of living 
conditions, the decline in tuberculosis was considerable 
in industrialized countries (the rate of infection dropped 
as much as from 200/100 000 inhabitants in 1900 to less 
than 10/100 000 inhabitants in 1980) (Rastogi et al., 
2001). However, since 1986, there has been a worldwide 
resurgence of tuberculosis (Newton et al., 2000) to which 
the HIV epidemic has undeniably been a major con-
tributor, as individuals with the immunological deficiency 
are more apt to develop the disease (Chin and Hopewell, 
1996; Iredia et al., 2011). According to the World Health 
Organization (WHO) report on global tuberculosis control, 
the   number   of   new   cases   was   estimated   at    9.2 
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million in 2006, or 139 cases per 100,000 inhabitants 
(WHO, 2009). The number of deaths from tuberculosis in 
2006 was estimated at 1.7 million of which 0.2 million 
occurred in HIV infected individuals. Developing countries 
continue to be the most effected by tuberculosis with a 
mortality rate of nearly 40% as compared to 7% in 
industrialized nations (Emile, 1996; Dharmarajan et al., 
2007). 
Two resistant forms of tuberculosis include multidrug-
resistant (MDR-TB) and extensively drug-resistant (XDR-
TB). MDR-TB is caused by Mycobacterium tuberculosis 
strains resistant to at least the two major first-line TB 
drugs, isoniazid (INH) and rifampicin (RIF). XDR-TB is 
caused by an MDR-TB strain also resistance to at least 
one of the three second-line injectable TB drugs 
(capreomycin, kanamycin or amikacin) in addition to any 
one of the fluoroquinolones. In 2007, the worldwide 
estimate was of 500 000 cases of MDR-TB; 85% of these 
were from 27 countries (of which 15, from the European 
region). At the end of 2008, 55 countries and territories 
had reported at least one case of XDR-TB (WHO, 2009). 
In Morocco, 500 to 1000 people die each year from 
tuberculosis.  According  to   the   last   figures   from   the  
  
 
 
Ministry of Health, the Kingdom registered 25 500 new 
cases in 2007, or 82 per 100 000 inhabitants. Seventy 
percent of these patients were between 15 and 45 years 
of age (Ben et al., 1996), mainly from the population 
residing in the most heavily populated urban areas. The 
sanitary services often receive patients in an advanced 
stage of disease. The delay in diagnosis not only 
endangers the patient but contributes to tuberculosis 
transmission as, without adequate treatment, an 
individual with active disease can infect on the average 
from 10 to 15 people in a one year time span. Also, 
inadequate treatment, either in dosage or duration, may 
result in acquired drug resistance to antituberculosis 
drugs. 
In today’s context, new drugs are a priority to better the 
control of mycobacterial infections and contribute to 
solution the problem of the emergence of strains resistant 
to antituberculosis agents. The purpose of this investi-
gation consists in the search for novel substances with an 
antimycobacterial effect from the Moroccan microbial 
flora, which has not been extensively explored in this 
respect. 
 
 
MATERIALS AND METHODS 
 
Mycobacterial strains 
 
All tests were carried out on non-pathogenic mycobacteria. These 
include: Mycobacterium aurum A+: a rapid growing 
scotochromogenic species, with a generation time of 6 h, having a 
similar spectrum of drug susceptibility to M. tuberculosis (Chung et 
al., 1995). 
Mycobacterium smegmatis MC2 155: a rapid growing non-
pigmented, thermophilic species with a generation time of 3 h. 
 
 
Isolation of microorganisms secreting substances with 
antimycobacterial effect 
 
Several samples (water, soil and water) were taken from different 
Moroccon ecological niches. The samples were kept under 
agitation for two hours. The supernatant was recovered after 
sedimentation of the heavier particles. Serial dilutions (of 10-1 to 10-
5) were carried out in sterile Luria Bertoni (LB) broth. An aliquot of 
70 µl of each dilution was spread on LB-agar previously inoculated 
with M. aurum A+ or M. smegmatis cultures having an optical 
density at 600 nm (D.O600nm) of 0.3. After incubation at 37°C for 48 
h, colonies surrounded by an inhibition zone were purified. The four 
isolates thus obtained were designated M, R, G and S. 
To confirm that the antimycobacterial effect of these isolates was 
due to secreted substances their cultures were filtered and the 
filtrate was tested on the mycobacteria using the well or diffusion 
method. Briefly, the strains were cultures in 50 ml of LB broth, for 
48 h at 37°C with agitation; the cultures were then centrifuged at 
6000 rpm for 5 min to remove bacteria in suspension. The 
supernatant was recovered and filtered using 0.45 µm porosity 
filters. The filtrate obtained was tested by depositing 100 µl in wells 
cut out from solid media in plates previously inoculated with 100 µl 
of mycobacterial culture (M. aurum or M. smegmatis) at D.O600 nm = 
0.3. The plates were incubated at 37°C for 48 h. After incubation, 
the presence or absence of an inhibition zone was reported. The 
inhibition tests were repeated three times for each strain. 
The  control  used   corresponded   to   a   culture    filtrate    from 
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Escherichia coli prepared under the same conditions. 100 µl of this 
filtrate was deposited in the wells prepared in plates previously 
inoculated with mycobacterial culture (M. aurum or M. smegmatis) 
at D.O600 nm = 0.3. The plates were incubated at 37°C for 48 h. After 
incubation, the presence or absence of an inhibition zone was 
reported. 
 
 
Activity spectrum of the isolates 
 
In order to get an idea on the spectrum of activity, the antimicrobial 
effect of the isolates under study was evaluated against the 
following bacteria: M. aurum A+, M. smegmatis MC2 155, E. coli 
DH5, Bacillus subtilis, Staphylococcus haemolyticus (Hassi et al., 
2007). 
A few colonies from young cultures of each isolate were 
deposited at the center of a plate previously inoculated with 100 µl 
of microbial culture (for E. coli, B. subtilis and S. haemolyticus the 
D.O600 nm was at 0.5, for M. aurum and M. smegmatis the D.O600 nm 
was at 0.3). The plates are incubated at 37°C for 48 h. After 
incubation, the presence or absence of an inhibition zone is 
reported. The tests were repeated three times for each strain. 
 
 
Confrontation test between the studied isolates 
 
A confrontation test between the studied isolates was carried out in 
order to determine if these bacteria produced the same active 
substance or not. For this, A few colonies from young cultures of 
each isolate were deposited at the center of a plate previously 
innoculated with 100 µl of culture of another of the isolates under 
study at D.O600 nm = 0.5. The plates were incubated at 37°C for 24 
h. After incubation, the presence or absence of an inhibition zone 
was reported. The confrontation test was repeated three times for 
each strain. 
 
 
Identification of the isolates 
 
The molecular identification of the isolates was carried out by 
polymerase chain reaction (PCR) amplification and sequencing of 
the 16S rRNA gene. In order to classify a microorganism within a 
genus or as a species, a number of criteria must be respected. The 
molecular definition of genus states that 16S rRNA sequence 
similarity should be superior or equal to 97%. Similarity superior to 
99% indicates identical species; on the other hand, no identification 
results if the similarity is inferior to 97% (Drancourt et al., 2000). 
DNA for the molecular studies was extracted from a young LB 
broth culture of the isolates (24 h). A 1 ml aliquot of the culture was 
transferred to a 1.5 ml microtube (Eppendorf, XXX) and centrifuged 
at 6000 rpm for 5 min. The pellet was resuspended in 100 l of 
sterile distilled water, frozen at -20°C for 30 min, then heated at 
95°C for 3 min. This thermolysis procedure was repeated twice in 
order to burst a large number of cells. After centifugation at 7000 
rpm for 10 min, 2 l of the supernatant (containing the DNA) were 
used in the amplification reaction (Rodrigues  et al., 2007). 
For, amplification, universal primers, fD1 (5’ 
AGAGTTTGATCCTGGCT CAG 3’) and Rs16 (5’ 
TACGGCTACCTTGTTACGACTT 3’), used in the identification of 
bacteria by sequencing of 16S rDNA were selected (Weisberg et 
al., 1991). The reaction mix was prepared in a final reaction volume 
of 20 l and contained: 4 l of Taq buffer (5x), 1.2 l of MgCl2 (25 
mM), 4 l of dNTPs (1 mM), 2 l of fD1 (10 M), 2 l of Rs16 (10 
M), 0.2 l of Taq polymerase (5 U/l), 4.6 l of pure H2O and 2 l 
of the DNA. The of amplification conditions consisted in an initial 
denaturation at 94°C for 5 min, 35 cycles of denaturation at 94°C 
for 30 s, annealing at 55°C for 45 s and extention at 72°C for 1 min 
30 s;   final  extension  was  performed  at   72°C   for  10  min.  The  
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Table 1. Antimycobacterial effect of the filtrate from the isolated strains. 
 
Filtrate from strain 
Diameter of the inhibition zone (cm) a 
Effect against MC2 b Effect against A+ c 
M 2.75 ± 0.15 3.22 ± 0.12 
R 2.29 ± 0.21 2.71 ± 0.11 
G 2.21 ± 0.22 2.56 ± 0.16 
S 1.78 ± 0.17 2.22 ± 0.18 
E. coli 0 0 
 
a Tested on Luria Bertoni agar, b MC2:  M. smegmatis, c A+:  M. aurum. 
 
 
 
amplified  fragment  of  approximately   1.5 kb   was   visualized   by 
electrophoresis using a 1% agarose gel. Two amplification controls 
were used, a negative control (T-) corresponding to a no template 
control, and a positive control (T+) corresponding to the 16S rDNA 
gene of B. subtilis.  
For sequencing, PCR products were purified using a PCR 
Product Purification Kit (JETquick, Genomed) as described by the 
manufacturer. Amplification was carried out using 2.7 µl of the DNA 
product. The sequencing reaction mixture contained 2 µl BigDye V 
1.1 and 0.25 µl of the primer (forward or reverse), PCR grade water 
was added for a final reaction volume of 10 µl. Amplification 
conditions were the following: initial denaturation at 96°C (3 min), 
35 cycles of denaturation at 96°C (20 seconds), annealing at 60°C 
(5 s) and extension at 60°C (4 min). All sequences were determined 
in an automated DNA capillary sequencer AbiPrism 3130XL 
Genetic Analyzer (Applied Biosystems, Foster City, USA) using 
BigDyeTM Terminator Cycle Sequencing Ready reaction Kit (PE 
Biosystems, Applied Biosystems, Foster City, USA). Two 
sequencing reactions were performed using the two primers used 
for PCR amplification. 
The sequences of were analyzed using the data base of the 
National Center for Biotechnology Information (NCBI) and the 
BLAST N program. 
Other than sequencing of the 16S rRNA gene, the molecular 
identification of the isolates under study was complemented using 
conventional preliminary tests: macroscopic observation, Gram 
stain and growth at 50°C (Meyer et al., 2004). 
 
 
Determination of the protein nature of the active substance of 
one of the isolates 
 
Precipitation of the active substance of the isolate by 
ammonium sulfate 
 
The precipitation protocol used was described by Shimei and 
collaborators for the purification and characterization of 
antimicrobial peptides (Subpeptin JM4-A et JM4-B), produced by B. 
subtilis JM4 (Shimei et al., 2005). Briefly, 100 ml of LB broth was 
inocularted with the selected strain and incubated at 37°C under 
agitation for 48 h. After incubation, it was centrifuged at 6000 rpm, 
at 4°C, for 5 min. The supernatant was recovered and 52.3 g of 
ammonium sulfate were progressively added under agitation. The 
mixture was left overnight under agitation at 4°C. The precipitate 
was centrifuged at 10000 rpm, at 10°C, for 20 min. The pellet was 
re-suspended in 200 l of buffer (potassium phosphate KH2PO4 50 
mM, pH = 6). 
The suspension obtained was dialyzed against the same buffer 
at 4°C for 12 h. The dialisate was filtered using a 0.45 µm de 
porosity filter. The effect of the dialisate was then tested (three 
times) against M. aurum and M. smegmatis using the well method. 
The controls used in this experiment were the LB  broth  (with  no 
inoculums) and the LB broth inoculated with E. coli. These controls 
were precipitated by ammonium sulfate, using the same protocol 
used for the precipitation of the active substance of the strain under 
study. The effect of the dialisate of these two controls was tested 
(three times) against M. aurum and M. smegmatis using the well 
method. 
 
 
Sensitivity of the isolate’s protein precipitate to Proteinase K 
 
A 100 µl volume of the filtered dialisate was added to 40 µl of a 
Proteinase K solution (1 mg/ml). The mixture was homogenized and 
incubated at 37°C for 3 h. The effect of the Proteinase K treated 
dialisate, was tested (three times) against M. aurum and M. 
smegmatis using the well method. The control was a solution of 
Proteinase K at the same concentration. 
 
 
RESULTS 
 
Isolation of microorganisms secreting substances 
with antimycobacterial effect 
 
Four bacterial strains (M, R, G and S) were isolated from 
the samples analyzed. They exerted growth inhibition 
against the indicator mycobacterial strains as seen by the 
formation of inhibition zones (Table 1). The inhibitory 
effect of the active substance from each strain was 
relatively more important against M. aurum than M. 
smegmatis. The E. coli filtrate, used as control, did not 
present any antimycobacterial activity. 
 
 
Activity spectrum of the isolates 
 
Results show that the isolates under study have an 
antimicrobial effect against Gram positive bacteria, Gram 
negative bacteria, and mycobacteria (Table 2). 
 
 
Confrontation test between the studied isolates 
 
In order to determine if the isolated strains produce the 
same active substances, confrontation tests were carried 
out between the various isolates. Results show that each 
isolate exerted an antimicrobial effect against the 
indicator strain as could be seen by  the  formation  of  an 
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Table 2. Activity spectrum of the isolates. 
 
Strains 
Inhibitory effect against a,b 
M. aurum 
(mycobacteria) 
M. smegmatis 
(mycobacteria) 
E. coli 
(Gram-) 
B. subtilis 
(Gram+) 
S. haemolyticus 
(Gram+) 
M + + + + + 
R + + + + + 
G + + + + + 
S + + + + + 
 
a Tested on Luria Bertoni agar. b +: presence of an inhibition zone. 
 
 
 
Table 3. Confrontation between the isolates. 
 
Strain deposited at the center of the plate Strain spread over the plate 
a
 
M R G S 
M - + + + 
R + - + + 
G + + - + 
S + + + - 
 
a Tested on Luria Bertoni agar. +: presence of an inhibition zone. -: absence of an inhibition zone. 
 
 
 
inhibition zone around the colonies deposited at the 
center of the plate (Table 3). 
 
 
Identification of the isolates 
 
According to the identification criteria described, results 
from the sequence analysis, indicated that the isolates 
under study belong to the genus Bacillus (Table 4). 
Concordantly, the isolates were Gram+ and capable of 
growth at 50°C. 
 
 
Determination of the protein nature of the active 
substance of isolate M 
 
Isolate M, which showed a more important activity than 
that of the other isolates, was selected to study the 
sensitivity of the isolate’s protein precipitate to Proteinase 
K. The precipitate of the active substance of the isolate 
inhibited mycobacterial growth creating an inhibition zone 
around the wells. This activity was eliminated upon 
treatment by Proteinase K (Table 5). There were no 
inhibition zones around the wells, with the test controls 
(LB broth and LB broth inoculated with E. coli). 
 
 
DISCUSSION 
 
Numerous microorganisms are used in industry in the 
production  of  metabolites:  enzymes,  antibiotics,  amino 
acids, vitamins, etc. The main microorganismes used by 
industry are Mycetes. However, some bacterial genus, 
such as Streptomyces and Bacillus, are also of industrial 
value (Xiaofeng et al., 2005). The production of 
antimicrobial compounds is known of an important 
number of bacteria. This phenomenon corresponds to a 
defensive mechanism of these bacteria, producing 
antibiotics, organic acids and lytic agents such as 
lysozymes. Furthermore, several types of protein 
exotoxins and bacteriocines are produced (Mota et al., 
2004). 
Since the 1950’s, antibiotherapy is the major defensive 
means against microbial infections. Amongst industrial 
fermentations, the production of antibiotics is one of the 
most important sectors. Screening for strains producing 
natural antibiotics has led to the production of first 
generation antibiotics. The majority of antibiotics of 
microbial origin are produced by actinomycetes and 
Bacillus (Duval, 1989; Xiaofeng et al., 2005). Bacteria of 
the genus Bacillus produce a variety of antimicrobial 
agents, although none used as antituberculosis agents. 
These are mainly peptides, lipopeptides and phenolic 
derivatives (Mota et al., 2004). The large majority of 
peptides are antibiotics. Others are known as antifungal, 
antitumoral and cytotoxic drugs (Sachtowakyama and 
Kuni, 1984). As examples we can mention the synthesis 
of iturin by B. subtilis, bacitracin by Bacillus licheniformis, 
tyrothricin by Bacillus brevis, and polymyxine by Bacillus 
polymyxa (Duval, 1989). 
In this investigation, water and soil and water samples 
from Morocco led to the isolation of four  bacterial  strains 
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Table 4. Identification of the isolates. 
 
Isolates 
under study 
Bacterial species showing a high 
degree of sequence similarity with 
the isolates under study 
Size of the sequenced 
fragment using primer 
Rs16 b (pb) 
% of similarity obtained 
using primer 
Rs16 
Size of the sequenced 
fragment using primer 
fD1 b (bp) 
% of similarity obtained 
using primer 
fD1 
M 
Bacillus sp. (FR773880.1)a 
500 
100 
561  
100 
Bacillus subtilis (HQ678671.1)a 100 100 
Bacillus amyloliquefaciens 
(HQ668178.1)a 100 100 
      
R 
Bacillus sp. (HQ728329.1)a 
609 
100 
618 
100 
Bacillus subtilis 
(HQ694434.1)a 100 100 
Bacillus amyloliquefaciens 
(HQ179100.1)a 100 100 
      
G 
Bacillus sp. (GU361655.1)a 
478 
100 
563 
100 
Bacillus subtilis (HQ323421.1)a 100 100 
Bacillus amyloliquefaciens 
(HM597236.1)a 100 100 
      
S 
Bacillus sp. (HQ603746.1)a 
535 
100 
623 
100 
Bacillus subtilis (HQ678662.1)a 100 100 
Bacillus amyloliquefaciens 
(HM992829.1)a 100 100 
 
 aAccess number National Center for Biotechnology Information (NCBI) database. bbp: base pairs. 
 
 
 
Table 5. Sensitivity of the active substance from isolate M to Proteinase K. 
 
Protein precipitate 
Diameter of the inhibition zone (cm)a 
Precipitate not subject to Proteinase K treatment  Precipitate treated by Proteinase K 
Effect on MC2 b Effect on A+ c  Effect on MC2 Effect on A+ 
Bacillus (isolate M) d 2.8 ± 0.15 3.3 ± 0.21  0 0 
E. coli 0 0  - - 
LB broth e 0 0  - - 
 
The control used was a solution of proteinase K. This control showed no antimycobacterial activity.- :Test not performed since the precipitate not subject to 
the Proteinase K treatment showed no effect.a Tested on Luria Bertoni agar.b MC2:  M. smegmatis.c A+:  M. aurum.d M:  Bacillus.  e LB: Luria Bertoni broth. 
  
 
 
 (M, R, G and S) which inhibited growth of M. smegmatis 
and M. aurum. Their antimycobacterial activity was 
demonstrated by the occurrence of growth inhibition 
zones around the colonies, resulting from the diffusion in 
the LB agar growth medium of the bioactive substances 
produced by the isolate. The study of the activity 
spectrum of the isolates showed that these exert an 
antimicrobial activity against Gram positive and Gram 
negative bacteria as well as mycobacteria. 
Inhibition zones were also produced when using the 
isolate filtrates. The absence of mycobacterial growth (M. 
smegmatis and M. aurum) around the wells containing 
the filtrate, confirmed that the antimycobacterial effect 
observed was due to diffusion in the agar medium of 
secreted substances. The inhibitory effect of the active 
substance from each of the strains was comparatively 
more active against M. aurum than M. smegmatis. This 
important inhibition could be due to the fact that M. aurum 
has a longer generation time than M. smegmatis, which 
would permit a longer diffusion time for the inhibitor. As 
the filtrates from the studied isolates are active against M. 
aurum, it is highly probable that they will also be active 
against M. tuberculosis since these two mycobacteria 
present the same antibiotic susceptibility profiles (Chung 
et al., 1995). 
Ammonium sulfate is widely used to precipitate water 
soluble proteins. It is one of the most common methods 
used to concentrate active substances of protein nature 
secreted by microorganisms in liquid medium. The active 
substance from the isolate showing the more important 
antimycobacterial activity was shown to precipitate by 
ammonium sulfate. The precipitate was also rendered 
inactive by Proteinase K. These results indicated the 
isolate’s activity was due to a protein substance. 
Sequencing of the 16S rRNA gene is presently the 
most commonly used molecular approach in bacterial 
phylogeny (Woese et al., 1990). It has led to the creation 
of large databases (Maidack et al., 1996; Van de Peer et 
al., 1999), whose use has allowed the identification of 
many environmental microorganisms as well as others 
that have been impossible to grow in culture (Relman et 
al., 1992; Strous et al., 1999). Using this methodology, 
the isolates were identified as Bacillus strains. These 
strains are Gram+ bacilli resistant to 50°C, confirming 
their classification in the genus Bacillus. The 
confrontation test showed that these isolates produced 
different active substances, which suggests that they are 
different strains although all from the genus Bacillus. The 
active substances could be antibiotics since most natural 
antimicrobial agents of bacterial origin are mainly 
synthesized by Bacillus and actinomycetes. 
Since mycobacteria can infect macrophages, the effect 
of the active substances isolated will be studied ex vivo. 
The effect will also be studied against pathogenic 
bacteria, namely those responsible for nosocomial 
infections. Finally, the substances shown to be active ex 
vivo (macrophages infected by mycobacteria) will be 
purified and their structures determined. 
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